Diabetes

In individuals with type 2 diabetes and comorbid obesity, the metabolic benefits of gastric bypass surgery and diet were similar and related to weight loss itself, but it had no clinically important effects independent of weight loss.

Individuals with recent-onset type 2 diabetes (T2D) accompanied by weight loss have a high risk for developing pancreatic cancer, according to a study published in JAMA Oncology.

In individuals with type 1 diabetes (T1D), bacterial infections are associated with an increased risk of coronary heart disease, according to a study published in the Journal of Internal Medicine.

Researchers developed a test to better determine which children will develop type 1 diabetes (T1D), moving closer to routine testing for newborns and potentially avoiding the risk of life-threatening complications.

Results from a large population-based cohort study, published in Arthritis Care & Research, found individuals with rheumatoid arthritis (RA) had a lower rate of incident type 2 diabetes (T2D) compared with the general non-RA population and cohorts with with hypertension, osteoarthritis (OA), and psoriatic arthritis (PsA).

Throughout the country, rising cases of coronavirus disease 2019 prove stressful for individuals most at risk of dying from the disease, including those with underlying conditions such as diabetes. Compounding this issue, new results from a study published in Psychoneuroendocrinology show the stress hormone cortisol is associated with higher blood sugar levels in individuals with type 2 diabetes (T2D), suggesting cortisol plays a detrimental role in contributing to glycemia in this population.

Results for EMPEROR-Reduced have been highly anticipated, as they are expected to set off a new round of competition in the drug class, which was first developed to treat type 2 diabetes.

Insulin cost-sharing caps may benefit children and young adults with type 1 diabetes (T1D), according to new research published in JAMA Pediatrics.

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with an almost 3-fold increased risk of diabetic ketoacidosis (DKA) in some patients with type 2 diabetes (T2D), according to data from a retrospective cohort study published in Annals of Internal Medicine.

The orders President Trump signed Friday include a deadline for the pharmaceutical industry to come up with their own plan by August 24 to lower prices.

IQVIA, a health information technology and clinical research company, recently announced a new collaboration with JDRF, the world’s largest nonprofit funder of type 1 diabetes (T1D) research. Together, the companies plan to develop a real-world research platform to facilitate evidence generation for T1D via non-identified patient-level data and analytics.

Children with type 1 diabetes (T1D) have a less desirable gut microbiome composition, potentially contributing to the development of the disease, according to new research published in the Journal of Clinical Endocrinology & Metabolism.

Even in individuals who don't have diabetes, hyperglycemia is an independent risk factor for COVID-19 mortality after 28 days of hospitalization, according to a study published in Diabetolgia.

The authors report the experience of one of the first Southern US communities to develop a comprehensive health care data repository for tracking processes and outcomes of care and identifying areas of greatest need.

California Governor Gavin Newsom announced yesterday the closure of indoor facilities statewide, amid a resurgence of coronavirus disease 2019 cases; US District Judge Theodore Chuang waived the in-person visit requirement to a hospital, clinic, or medical office to receive an abortion pill, due to the pandemic; a diet high in fruits and vegetables may halve the risk of developing type 2 diabetes.

In individuals with type 2 diabetes (T2D), sleep problems are associated with disturbances in cortisol responses to stress, in addition to changes in diurnal cortisol output, according to a study published in Psychoneuroendocrinology.

Heart failure yields the greatest 5-year mortality risk for individuals newly diagnosed with type 2 diabetes (T2D) compared with any other heart or kidney diseases, according to a study published in Circulation: Cardiovascular Quality and Outcomes.

Individuals living with type 1 and type 2 diabetes (T1D and T2D, respectively) are at greater risk of bone fractures, according to a systematic review update published in Bone.

Amid progress in diabetes treatments and technology, the rate of amputations rose 50% between 2009 and 2015. African American patients lose limbs at triple the rate of other groups. The mission of the Affordable Care Act—spend more to prevent disease and complications, and save money later—has bypassed many of these patients for one reason: they lack access to care.

This article addresses what employers need to know about food as medicine and offers practical steps to reduce barriers for their employee populations.

The coronavirus disease 2019 (COVID-19) pandemic will hopefully be a wakeup call to take diabetes more seriously and to work to prevent diabetes and its complications, said Robert Gabbay, MD, PhD, chief medical and scientific officer of the American Diabetes Association.

Metformin-based therapy may be an optimal first-line treatment for patients with type 2 diabetes (T2D) and low cardiovascular risk, according to a systematic review and network meta-analysis published in Annals of Internal Medicine.

Peer support is a huge advantage of technological health interventions for teens with type 1 diabetes (T1D), while integrating technology with physical activities is important when promoting healthy lifestyles, said Tara Kaushal, MD, physician and clinical researcher at Joslin Diabetes Center.

Among Medicare enrollees, there was substantial between-practice variation in the use of second-generation diabetes drugs between 2007 and 2015, according to a study published in JAMA Network Open. Data also revealed a concentration of use among a few prescribers and practices, who were responsible for widespread early diffusion.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.